resveratrol has been researched along with muramidase in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, Y; Kubo, M; Okuda, H | 1 |
| Gazova, Z; Kurin, E; Mučaji, P; Nagy, M; Siposova, K | 1 |
| Ghasemi, A; Meratan, AA; Nemat-Gorgani, M; Shariatizi, S | 1 |
| de Athayde Moncorvo Collado, A; Dupuy, FG; Minahk, C; Morero, RD | 1 |
| Bhat, R; Kamal Zaidi, F | 1 |
| Bao, C; Jin, J; Li, D; Li, Y; Liu, M; Luo, J; Ren, F; Teng, W; Xiong, W; Yang, S; Zhang, C; Zhang, M; Zhao, L | 1 |
6 other study(ies) available for resveratrol and muramidase
| Article | Year |
|---|---|
Effects of stilbenes isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclear leukocytes.
Topics: Arachidonic Acid; Autoradiography; Calcimycin; Cell Degranulation; Cyclic AMP; Fatty Acids, Unsaturated; Glucuronidase; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Leukotriene C4; Lysosomes; Muramidase; Neutrophils; Plant Roots; Plants, Medicinal; Resveratrol; Stilbenes; Structure-Activity Relationship | 1995 |
Amyloid aggregation of lysozyme: the synergy study of red wine polyphenols.
Topics: Amyloid; Animals; Antioxidants; Caffeic Acids; Chickens; Models, Molecular; Muramidase; Polyphenols; Quercetin; Resveratrol; Stilbenes; Wine | 2013 |
Inhibition of amyloid fibrillation and cytotoxicity of lysozyme fibrillation products by polyphenols.
Topics: Amyloid; Animals; Antioxidants; Cell Shape; Cell Survival; Cinnamates; Depsides; Drug Evaluation, Preclinical; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Muramidase; PC12 Cells; Protein Aggregation, Pathological; Protein Stability; Protein Structure, Secondary; Rats; Resveratrol; Rosmarinic Acid; Stilbenes | 2015 |
Cholesterol induces surface localization of polyphenols in model membranes thus enhancing vesicle stability against lysozyme, but reduces protection of distant double bonds from reactive-oxygen species.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antioxidants; Catechin; Cholesterol; Dimyristoylphosphatidylcholine; Flavanones; Fluorescence Polarization; Hydrophobic and Hydrophilic Interactions; Lignans; Linoleic Acid; Lipid Bilayers; Lipid Peroxidation; Liposomes; Muramidase; Reactive Oxygen Species; Resveratrol; Stilbenes; Surface Properties | 2016 |
Resveratrol Interferes with an Early Step in the Fibrillization Pathway of Human Lysozyme and Modulates it towards Less-Toxic, Off-Pathway Aggregates.
Topics: Humans; Models, Molecular; Molecular Structure; Muramidase; Resveratrol | 2018 |
The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease.
Topics: Animals; Diet, High-Fat; Galactose; Hep G2 Cells; Humans; Liver; Male; Mice, Inbred C57BL; Micelles; Muramidase; Nanoparticles; Non-alcoholic Fatty Liver Disease; Resveratrol; Starch | 2019 |